Recalled products pose significant risk to patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke.
During packaging and labeling, tablets from one product type may have carried over into packaging of another product.
Use of an inhaled product with glass particles has the potential to cause choking which could be life-threatening.
Inexpensive dual transistors work as well as do legacy matched...
Developing the transfer functions lets you customize the...
A comparator autoranges to ensure that the automatic-gain-control section sees a signal...
Oral contraceptive daily regimen may be incorrect and could leave women without adequate contraception, and at risk for unintended pregnancy.
Consequences of using the incorrectly labeled product may result in high potassium blood levels (hyperkalemia) or high sodium levels in the blood (hypernatremia).
Potential adverse events after intravenous administration of solutions containing particulates may include emboli and result in disruption of blood flow, causing tissue/organ damage.
The risks and benefits of continuing treatment with Tysabri should be carefully considered in patients who are found to be anti-JCV antibody positive and have one or more of the other known risk factors for PML.
Systemic absorption of topically administered Minoxidil could cause low blood pressure, heart palpitations and associated cardiac symptoms.
Possibility of an adverse reaction or unknown drug-drug interaction.
You can make a wireless temps system with two...
Careful crystal selection and an FPGA are key to...
The circuit takes advantage of an identical photo-FET as a feedback...
Quickly test a cable containing twisted-wire pairs and detect open or reversed pairs, shorted...
New Boxed Warning and Contraindication highlighting these risks added to product labeling.
UPDATED 01/12/2012. FDA is updating healthcare professionals and the public about preliminary findings from ongoing investigations following the voluntary recall of CardioGen-82.
Failure of therapy could result in the potential for harm or death of a ventilator-dependent patient.
Particulate matter in injections can be harmful when introduced into the bloodstream.
Pages